MedTrace Logo

Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)

NCT03478826 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 635

Last updated 2026-04-29

No results posted yet for this study

Summary

To develop a repository of blood samples from patients with ILD to support future studies into the development of such biomarkers. Patients with pneumonia and healthy patients will also be recruited as a control group.

Conditions

Interventions

OTHER

ILD

100 cc of blood collected from a total of 250 ILD patients. This includes IPF (n=100), fibrotic NSIP (n=50), chronic hypersensitivity pneumonia (n=20), sarcoidosis(n=50), progressive rheumatoid lung disease (n=10) and scleroderma lung disease (n=20)), 10 patients with other fibrosing disease (fibrosing mediastinitis), and 50 patients with lymphangioleiomyomatosis

OTHER

Healthy

100 cc of blood collected from a total of 25 healthy volunteers in order to compare with the ILD participants.

OTHER

Pneumonia

100 cc of blood collected from a total of 100 participants with a diagnosis of pneumonia in order to compare with the ILD participants.

Sponsors & Collaborators

Principal Investigators

  • Eva M Carmona Porquera, MD, PhD · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2028-01-31
Completion
2028-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03478826 on ClinicalTrials.gov